The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction
Young, F.E.; Nightingale, S.L.; Temple, R.A.
JAMA 259(21): 3158-3160
1988
ISSN/ISBN: 0098-7484 PMID: 3367492 Document Number: 316931
Document emailed within 1 workday
Related Documents
1980: The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group Circulation 62(6 Pt 2): V79-V84Agustí, Aònia.; Diogène, E. 2004: Primary prevention of acute myocardial infarction with aspirin Medicina Clinica 122(15): 592-594
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
1988: Position statement. Physicians' Health Study report on aspirin. American Heart Association Circulation 77(6): 1447A
Gaciong, Z. 2006: Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study Kardiologia Polska 64(5): 548
O'Shea, E.B. 2001: A study of the use of aspirin by general practitioners in suspected myocardial infarction Irish Medical Journal 94(2): 48-50; 52
1988: Study suggests added benefit from combined aspirin--streptokinase therapy after myocardial infarction Clinical Pharmacy 7(11): 785-786
Yokoyama, T.; Yamashita, K.; Yamasaki, F.; Ueta, T.; Manabe, M.; Nishiyama, T. 2003: Aspirin reversal--an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin Masui. Japanese Journal of Anesthesiology 52(4): 399-401
Szmidt, M.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Grzegorczyk, J. 1991: Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity Pneumonologia i Alergologia Polska 59(1-2): 16-21
Katz, L.B.; Shriver, D.A. 1989: Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin Journal of Pharmacology and Experimental Therapeutics 251(2): 774-781
Petroski, D. 1986: A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies American Journal of Gastroenterology 81(1): 26-28
Thelle, D.S. 1988: Aspirin and myocardial infarction--a gimmick from the media? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(13): 1055-1056
Gulløv, A.L.; Koefoed, B.G.; Petersen, P.; Pedersen, T.S.; Andersen, E.D.; Godtfredsen, J.; Boysen, G. 1998: Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Archives of Internal Medicine 158(14): 1513-1521
Bretagne, J.F.; Feuillu, A.; Gosselin, M.; Gastard, J. 1984: Aspirin and gastroduodenal toxicity. a double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects Gastroenterologie Clinique et Biologique 8(1): 28-32
De Caterina, R. 2001: The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(6): 681-684
Luo, Y. 1993: Improvement of prostacyclin-thromboxane A2 balance in patients with acute myocardial infarction by intermittent aspirin Zhonghua Xin Xue Guan Bing Za Zhi 21(4): 219
Bar Dayan, Y.; Amital, H.; Levy, Y.; Shoenfeld, Y. 1996: Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction Israel Journal of Medical Sciences 32(5): 288-291
Madsen, J.K.; Pedersen, F.; Amtoft, A.; Deding, A.; Grande, P.; Hansen, J.N.; Hilden, M.; Hornum, I.; Jensen, T.; Lindskov, J. 1989: Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2 Ugeskrift for Laeger 151(40): 2565-2569
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Burrill, P.D. 2010: Aspirin in primary prevention. Evidence is lacking Bmj 340: C1613